BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9748780)

  • 1. [Statins have other beneficial properties besides their cholesterol lowering effect].
    Eriksson M
    Lakartidningen; 1998 Aug; 95(35):3670-2. PubMed ID: 9748780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-lipid-related effects of statins.
    Bellosta S; Ferri N; Bernini F; Paoletti R; Corsini A
    Ann Med; 2000 Apr; 32(3):164-76. PubMed ID: 10821323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin-stimulated nitric oxide release from endothelium.
    Dobrucki LW; Kalinowski L; Dobrucki IT; Malinski T
    Med Sci Monit; 2001; 7(4):622-7. PubMed ID: 11433186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
    Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
    Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
    Turner NA; Midgley L; O'Regan DJ; Porter KE
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of isoprenoids in vascular smooth muscle: potential benefits of statins unrelated to cholesterol lowering.
    Hughes AD
    J Hum Hypertens; 1996 Jun; 10(6):387-90. PubMed ID: 8872802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statins: possibly more than just lowering of the lipid level].
    Visseren FL; Lansberg PJ; Erkelens DW; Kastelein JJ
    Ned Tijdschr Geneeskd; 2000 Feb; 144(7):316-21. PubMed ID: 10707742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol.
    Sotiriou CG; Cheng JW
    Ann Pharmacother; 2000 Dec; 34(12):1432-9. PubMed ID: 11144702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antilipemic agents and atherothrombosis. Effects of antilipemic agents on blood platelet function, coagulation and fibrinolysis].
    Sinzinger H
    Dtsch Med Wochenschr; 1998 Sep; 123(38):1116-22. PubMed ID: 9787294
    [No Abstract]   [Full Text] [Related]  

  • 12. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hyperlipidemia in cardiac transplant recipients.
    Bilchick KC; Henrikson CA; Skojec D; Kasper EK; Blumenthal RS
    Am Heart J; 2004 Aug; 148(2):200-10. PubMed ID: 15308989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Additional effects of statins independent of the cholesterol-lowering as yet not shown to be clinically relevant].
    Stalenhoef AF; Stehouwer CD
    Ned Tijdschr Geneeskd; 2000 Feb; 144(7):308-10. PubMed ID: 10707739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
    Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a role for statins in immunomodulation.
    Mach F
    Mol Interv; 2002 Dec; 2(8):478-80. PubMed ID: 14993398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins decrease serotonin-induced contractions in coronary arteries of swine in vitro.
    Crespo MJ; Quidgley JA
    Pharmacology; 2006; 76(3):141-7. PubMed ID: 16428899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells.
    Verhulst A; D'Haese PC; De Broe ME
    J Am Soc Nephrol; 2004 Sep; 15(9):2249-57. PubMed ID: 15339974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.